Teva finds regulatory VP at FDA gate

Generics-maker Teva Pharmaceutical has hired Gary Buehler, FDA's former head of generic drugs and outgoing deputy director, Office of Pharmaceutical Science. Buehler is set to retire from the FDA at the end of this week. He'll join Teva as VP for regulatory strategic operations. The drugmaker no doubt hopes to tap Buehler's insider insights for generics and biosimilars. Article

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.